Homeostatic imbalance of regulatory and effector T cells due to IL-2 deprivation amplifies murine lupus-Reference-Cited by-同舟云学术

Homeostatic imbalance of regulatory and effector T cells due to IL-2 deprivation amplifies murine lupus

Published:2009-12-14 Issue:1 Volume:107 Page:204-209
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:Proceedings of the National Academy of Sciences

Author:

Humrich J. Y.,Morbach H.,Undeutsch R.,Enghard P.,Rosenberger S.,Weigert O.,Kloke L.,Heimann J.,Gaber T.,Brandenburg S.,Scheffold A.,Huehn J.,Radbruch A.,Burmester G.-R.,Riemekasten G.

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference31 articles.

1. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

2. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self

3. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice

4. Human regulatory T cells and autoimmunity

5. The Biology of Interleukin-2

Cited by 160 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Animal models of systemic lupus erythematosus (SLE);Dubois' Lupus Erythematosus and Related Syndromes;2025

2. Promising roles of combined therapy based on immune response and iron metabolism in systemic lupus erythematosus;International Immunopharmacology;2024-09

3. Therapy with regulatory T-cell infusion in autoimmune diseases and organ transplantation: A review of the strengths and limitations;Transplant Immunology;2024-08

4. Monoclonal antibodies targeting interleukins for systemic lupus erythematosus: updates in early clinical drug development;Expert Opinion on Investigational Drugs;2024-07-09

5. Novel therapeutic strategies targeting abnormal T-cell signaling in systemic lupus erythematosus;Clinical Immunology;2024-05